Clinical Trial Update: Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions [Phase 2]

View source ↗

Summary

Phase 2 trial of a cobalt-chromium reservoir-based sirolimus-eluting stent for native coronary artery lesions was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution
• Sirolimus (Sirolimus)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Disease | Phase 2 | Status: TERMINATED